Loading…
Did AFP-L3 save ultrasonography in community screening?
In the community screening, those subjects with elevated serum alpha-fetoprotein (AFP) required further abdomen ultrasonography (US) to detect hepatocellular carcinoma (HCC). However, some chronic hepatitis patients might have elevated AFP. AFP-L3, has been proposed to differentiate HCC and hepatiti...
Saved in:
| Published in: | The Kaohsiung journal of medical sciences 2018-10, Vol.34 (10), p.583-587 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c5813-4b94ad2837191f3dc59046da81fc07da132192a1dd4a745983e53e956a6d7ca53 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c5813-4b94ad2837191f3dc59046da81fc07da132192a1dd4a745983e53e956a6d7ca53 |
| container_end_page | 587 |
| container_issue | 10 |
| container_start_page | 583 |
| container_title | The Kaohsiung journal of medical sciences |
| container_volume | 34 |
| creator | Yen, Chih-Wei Kuo, Yuan-Hung Wang, Jing-Houng Chang, Kuo-Chin Kee, Kwong-Ming Hung, Shu-Feng Chen, Yi Tsai, Lin-San Chen, Shu-Chuan Hung, Chao-Hung Lu, Sheng-Nan |
| description | In the community screening, those subjects with elevated serum alpha-fetoprotein (AFP) required further abdomen ultrasonography (US) to detect hepatocellular carcinoma (HCC). However, some chronic hepatitis patients might have elevated AFP. AFP-L3, has been proposed to differentiate HCC and hepatitis in elevated AFP cases in Japan for decades, but the utility is limited outside Japan. We conducted this study to elucidate the role of AFP-L3 in the community and the possibility of saving unnecessary US. A total of 56,702 subjects underwent a large-scale healthcare screening in Tainan county in 2004. Among them, 286 residents with AFP more than 20 ng/ml further received US and 169 (59%) had stored baseline sera were enrolled into this study in 2013. Their AFP and AFP-L3 levels were further detected. HCC patients were initially identified through US and personal history. Among 169 studied sera, only 148 (87.6%) samples still had AFP level more than 20 ng/ml after a 10-years frozen period. The decrease of AFP level was significant (481.3 ± 2093.8 ng/ml and 456.1 ± 2095.3 ng/ml in paired-T test, p |
| doi_str_mv | 10.1016/j.kjms.2018.05.005 |
| format | article |
| fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_800ae4a06aee4e4bb303b875fd31090c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A722054345</galeid><els_id>S1607551X18301232</els_id><doaj_id>oai_doaj_org_article_800ae4a06aee4e4bb303b875fd31090c</doaj_id><sourcerecordid>A722054345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5813-4b94ad2837191f3dc59046da81fc07da132192a1dd4a745983e53e956a6d7ca53</originalsourceid><addsrcrecordid>eNqNkVGL1DAUhYso7rj6B3yQgi--tN40SZOAIMPq6uqIPij4FtLkdsw4bWaTzi7z7zdj1wVBRPIQCOecnHu_onhKoCZA2peb-udmSHUDRNbAawB-r1g0jEAlWw73iwVpQVSck-8nxaOUNgCsVUo8LE4oUFBMikUh3nhXLs-_VCtaJnOF5X47RZPCGNbR7H4cSj-WNgzDfvTToUw2Io5-XL9-XDzozTbhk9v7tPh2_vbr2ftq9fndxdlyVVkuCa1Yp5hxjaSCKNJTZ7nKJZyRpLcgnCG0IaoxxDlmBONKUuQUFW9N64Q1nJ4WF3OuC2ajd9EPJh50MF7_eghxrU2cvN2ilgAGmYHWIDJkXZen7KTgvaMEFNic9WLO2sVwucc06cEni9utGTHsk24IUYpIwUiWPp-la5OT_diHvBV7lOulaBrgjLJjufovqnwcDt6GEXuf3_8wNLPBxpBSxP5uIgL6yFRv9JGpPjLVwHVmmk3PbmvvuwHdneU3xCwQs-A6f3f4j0j98cOnhkuana9mJ2aEVx6jTtbjaNH5iHbKO_b_anYDmmW_1Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2119918741</pqid></control><display><type>article</type><title>Did AFP-L3 save ultrasonography in community screening?</title><source>Wiley-Blackwell Open Access Collection</source><source>ScienceDirect Journals</source><creator>Yen, Chih-Wei ; Kuo, Yuan-Hung ; Wang, Jing-Houng ; Chang, Kuo-Chin ; Kee, Kwong-Ming ; Hung, Shu-Feng ; Chen, Yi ; Tsai, Lin-San ; Chen, Shu-Chuan ; Hung, Chao-Hung ; Lu, Sheng-Nan</creator><creatorcontrib>Yen, Chih-Wei ; Kuo, Yuan-Hung ; Wang, Jing-Houng ; Chang, Kuo-Chin ; Kee, Kwong-Ming ; Hung, Shu-Feng ; Chen, Yi ; Tsai, Lin-San ; Chen, Shu-Chuan ; Hung, Chao-Hung ; Lu, Sheng-Nan</creatorcontrib><description>In the community screening, those subjects with elevated serum alpha-fetoprotein (AFP) required further abdomen ultrasonography (US) to detect hepatocellular carcinoma (HCC). However, some chronic hepatitis patients might have elevated AFP. AFP-L3, has been proposed to differentiate HCC and hepatitis in elevated AFP cases in Japan for decades, but the utility is limited outside Japan. We conducted this study to elucidate the role of AFP-L3 in the community and the possibility of saving unnecessary US. A total of 56,702 subjects underwent a large-scale healthcare screening in Tainan county in 2004. Among them, 286 residents with AFP more than 20 ng/ml further received US and 169 (59%) had stored baseline sera were enrolled into this study in 2013. Their AFP and AFP-L3 levels were further detected. HCC patients were initially identified through US and personal history. Among 169 studied sera, only 148 (87.6%) samples still had AFP level more than 20 ng/ml after a 10-years frozen period. The decrease of AFP level was significant (481.3 ± 2093.8 ng/ml and 456.1 ± 2095.3 ng/ml in paired-T test, p < 0.001). Focusing on these 148 cases, 23 (15.5%) HCC cases were diagnosed at the baseline screening. There was no difference of AFP-L3 level between HCC and non-HCC cases. Using AFP-L3 to predict HCC, the area under Receiver Operating Characteristic curve was as low as 52%, p = 0.757. Too long frozen period might lower the quality of stored sera. Additionally, AFP-L3 might not provide more information for HCC identification to save advanced US examinations in the community screening.</description><identifier>ISSN: 1607-551X</identifier><identifier>EISSN: 2410-8650</identifier><identifier>DOI: 10.1016/j.kjms.2018.05.005</identifier><identifier>PMID: 30309487</identifier><language>eng</language><publisher>China (Republic : 1949- ): Elsevier Taiwan LLC</publisher><subject>Aged ; Alpha-fetoprotein ; Alpha-fetoprotein-L3 ; alpha-Fetoproteins - analysis ; Biomarkers, Tumor - blood ; Carcinoma, Hepatocellular - blood ; Carcinoma, Hepatocellular - diagnosis ; Carcinoma, Hepatocellular - diagnostic imaging ; Community hepatocellular carcinoma screening ; Diagnostic reagents industry ; Hepatitis ; Humans ; Liver Neoplasms - blood ; Liver Neoplasms - diagnosis ; Liver Neoplasms - diagnostic imaging ; Mass Screening - statistics & numerical data ; Middle Aged ; Retrospective Studies ; Ultrasonography ; Ultrasonography - statistics & numerical data ; Ultrasound imaging</subject><ispartof>The Kaohsiung journal of medical sciences, 2018-10, Vol.34 (10), p.583-587</ispartof><rights>2018</rights><rights>2018 Kaohsiung Medical University</rights><rights>Copyright © 2018. Published by Elsevier Taiwan LLC.</rights><rights>COPYRIGHT 2018 John Wiley & Sons, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5813-4b94ad2837191f3dc59046da81fc07da132192a1dd4a745983e53e956a6d7ca53</citedby><cites>FETCH-LOGICAL-c5813-4b94ad2837191f3dc59046da81fc07da132192a1dd4a745983e53e956a6d7ca53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2Fj.kjms.2018.05.005$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1607551X18301232$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,11562,27924,27925,45780,46052,46476</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30309487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yen, Chih-Wei</creatorcontrib><creatorcontrib>Kuo, Yuan-Hung</creatorcontrib><creatorcontrib>Wang, Jing-Houng</creatorcontrib><creatorcontrib>Chang, Kuo-Chin</creatorcontrib><creatorcontrib>Kee, Kwong-Ming</creatorcontrib><creatorcontrib>Hung, Shu-Feng</creatorcontrib><creatorcontrib>Chen, Yi</creatorcontrib><creatorcontrib>Tsai, Lin-San</creatorcontrib><creatorcontrib>Chen, Shu-Chuan</creatorcontrib><creatorcontrib>Hung, Chao-Hung</creatorcontrib><creatorcontrib>Lu, Sheng-Nan</creatorcontrib><title>Did AFP-L3 save ultrasonography in community screening?</title><title>The Kaohsiung journal of medical sciences</title><addtitle>Kaohsiung J Med Sci</addtitle><description>In the community screening, those subjects with elevated serum alpha-fetoprotein (AFP) required further abdomen ultrasonography (US) to detect hepatocellular carcinoma (HCC). However, some chronic hepatitis patients might have elevated AFP. AFP-L3, has been proposed to differentiate HCC and hepatitis in elevated AFP cases in Japan for decades, but the utility is limited outside Japan. We conducted this study to elucidate the role of AFP-L3 in the community and the possibility of saving unnecessary US. A total of 56,702 subjects underwent a large-scale healthcare screening in Tainan county in 2004. Among them, 286 residents with AFP more than 20 ng/ml further received US and 169 (59%) had stored baseline sera were enrolled into this study in 2013. Their AFP and AFP-L3 levels were further detected. HCC patients were initially identified through US and personal history. Among 169 studied sera, only 148 (87.6%) samples still had AFP level more than 20 ng/ml after a 10-years frozen period. The decrease of AFP level was significant (481.3 ± 2093.8 ng/ml and 456.1 ± 2095.3 ng/ml in paired-T test, p < 0.001). Focusing on these 148 cases, 23 (15.5%) HCC cases were diagnosed at the baseline screening. There was no difference of AFP-L3 level between HCC and non-HCC cases. Using AFP-L3 to predict HCC, the area under Receiver Operating Characteristic curve was as low as 52%, p = 0.757. Too long frozen period might lower the quality of stored sera. Additionally, AFP-L3 might not provide more information for HCC identification to save advanced US examinations in the community screening.</description><subject>Aged</subject><subject>Alpha-fetoprotein</subject><subject>Alpha-fetoprotein-L3</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Biomarkers, Tumor - blood</subject><subject>Carcinoma, Hepatocellular - blood</subject><subject>Carcinoma, Hepatocellular - diagnosis</subject><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Community hepatocellular carcinoma screening</subject><subject>Diagnostic reagents industry</subject><subject>Hepatitis</subject><subject>Humans</subject><subject>Liver Neoplasms - blood</subject><subject>Liver Neoplasms - diagnosis</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Mass Screening - statistics & numerical data</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Ultrasonography</subject><subject>Ultrasonography - statistics & numerical data</subject><subject>Ultrasound imaging</subject><issn>1607-551X</issn><issn>2410-8650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqNkVGL1DAUhYso7rj6B3yQgi--tN40SZOAIMPq6uqIPij4FtLkdsw4bWaTzi7z7zdj1wVBRPIQCOecnHu_onhKoCZA2peb-udmSHUDRNbAawB-r1g0jEAlWw73iwVpQVSck-8nxaOUNgCsVUo8LE4oUFBMikUh3nhXLs-_VCtaJnOF5X47RZPCGNbR7H4cSj-WNgzDfvTToUw2Io5-XL9-XDzozTbhk9v7tPh2_vbr2ftq9fndxdlyVVkuCa1Yp5hxjaSCKNJTZ7nKJZyRpLcgnCG0IaoxxDlmBONKUuQUFW9N64Q1nJ4WF3OuC2ajd9EPJh50MF7_eghxrU2cvN2ilgAGmYHWIDJkXZen7KTgvaMEFNic9WLO2sVwucc06cEni9utGTHsk24IUYpIwUiWPp-la5OT_diHvBV7lOulaBrgjLJjufovqnwcDt6GEXuf3_8wNLPBxpBSxP5uIgL6yFRv9JGpPjLVwHVmmk3PbmvvuwHdneU3xCwQs-A6f3f4j0j98cOnhkuana9mJ2aEVx6jTtbjaNH5iHbKO_b_anYDmmW_1Q</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Yen, Chih-Wei</creator><creator>Kuo, Yuan-Hung</creator><creator>Wang, Jing-Houng</creator><creator>Chang, Kuo-Chin</creator><creator>Kee, Kwong-Ming</creator><creator>Hung, Shu-Feng</creator><creator>Chen, Yi</creator><creator>Tsai, Lin-San</creator><creator>Chen, Shu-Chuan</creator><creator>Hung, Chao-Hung</creator><creator>Lu, Sheng-Nan</creator><general>Elsevier Taiwan LLC</general><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>6I.</scope><scope>AAFTH</scope><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>201810</creationdate><title>Did AFP-L3 save ultrasonography in community screening?</title><author>Yen, Chih-Wei ; Kuo, Yuan-Hung ; Wang, Jing-Houng ; Chang, Kuo-Chin ; Kee, Kwong-Ming ; Hung, Shu-Feng ; Chen, Yi ; Tsai, Lin-San ; Chen, Shu-Chuan ; Hung, Chao-Hung ; Lu, Sheng-Nan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5813-4b94ad2837191f3dc59046da81fc07da132192a1dd4a745983e53e956a6d7ca53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Alpha-fetoprotein</topic><topic>Alpha-fetoprotein-L3</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Biomarkers, Tumor - blood</topic><topic>Carcinoma, Hepatocellular - blood</topic><topic>Carcinoma, Hepatocellular - diagnosis</topic><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Community hepatocellular carcinoma screening</topic><topic>Diagnostic reagents industry</topic><topic>Hepatitis</topic><topic>Humans</topic><topic>Liver Neoplasms - blood</topic><topic>Liver Neoplasms - diagnosis</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Mass Screening - statistics & numerical data</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Ultrasonography</topic><topic>Ultrasonography - statistics & numerical data</topic><topic>Ultrasound imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yen, Chih-Wei</creatorcontrib><creatorcontrib>Kuo, Yuan-Hung</creatorcontrib><creatorcontrib>Wang, Jing-Houng</creatorcontrib><creatorcontrib>Chang, Kuo-Chin</creatorcontrib><creatorcontrib>Kee, Kwong-Ming</creatorcontrib><creatorcontrib>Hung, Shu-Feng</creatorcontrib><creatorcontrib>Chen, Yi</creatorcontrib><creatorcontrib>Tsai, Lin-San</creatorcontrib><creatorcontrib>Chen, Shu-Chuan</creatorcontrib><creatorcontrib>Hung, Chao-Hung</creatorcontrib><creatorcontrib>Lu, Sheng-Nan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals</collection><jtitle>The Kaohsiung journal of medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yen, Chih-Wei</au><au>Kuo, Yuan-Hung</au><au>Wang, Jing-Houng</au><au>Chang, Kuo-Chin</au><au>Kee, Kwong-Ming</au><au>Hung, Shu-Feng</au><au>Chen, Yi</au><au>Tsai, Lin-San</au><au>Chen, Shu-Chuan</au><au>Hung, Chao-Hung</au><au>Lu, Sheng-Nan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Did AFP-L3 save ultrasonography in community screening?</atitle><jtitle>The Kaohsiung journal of medical sciences</jtitle><addtitle>Kaohsiung J Med Sci</addtitle><date>2018-10</date><risdate>2018</risdate><volume>34</volume><issue>10</issue><spage>583</spage><epage>587</epage><pages>583-587</pages><issn>1607-551X</issn><eissn>2410-8650</eissn><abstract>In the community screening, those subjects with elevated serum alpha-fetoprotein (AFP) required further abdomen ultrasonography (US) to detect hepatocellular carcinoma (HCC). However, some chronic hepatitis patients might have elevated AFP. AFP-L3, has been proposed to differentiate HCC and hepatitis in elevated AFP cases in Japan for decades, but the utility is limited outside Japan. We conducted this study to elucidate the role of AFP-L3 in the community and the possibility of saving unnecessary US. A total of 56,702 subjects underwent a large-scale healthcare screening in Tainan county in 2004. Among them, 286 residents with AFP more than 20 ng/ml further received US and 169 (59%) had stored baseline sera were enrolled into this study in 2013. Their AFP and AFP-L3 levels were further detected. HCC patients were initially identified through US and personal history. Among 169 studied sera, only 148 (87.6%) samples still had AFP level more than 20 ng/ml after a 10-years frozen period. The decrease of AFP level was significant (481.3 ± 2093.8 ng/ml and 456.1 ± 2095.3 ng/ml in paired-T test, p < 0.001). Focusing on these 148 cases, 23 (15.5%) HCC cases were diagnosed at the baseline screening. There was no difference of AFP-L3 level between HCC and non-HCC cases. Using AFP-L3 to predict HCC, the area under Receiver Operating Characteristic curve was as low as 52%, p = 0.757. Too long frozen period might lower the quality of stored sera. Additionally, AFP-L3 might not provide more information for HCC identification to save advanced US examinations in the community screening.</abstract><cop>China (Republic : 1949- )</cop><pub>Elsevier Taiwan LLC</pub><pmid>30309487</pmid><doi>10.1016/j.kjms.2018.05.005</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1607-551X |
| ispartof | The Kaohsiung journal of medical sciences, 2018-10, Vol.34 (10), p.583-587 |
| issn | 1607-551X 2410-8650 |
| language | eng |
| recordid | cdi_doaj_primary_oai_doaj_org_article_800ae4a06aee4e4bb303b875fd31090c |
| source | Wiley-Blackwell Open Access Collection; ScienceDirect Journals |
| subjects | Aged Alpha-fetoprotein Alpha-fetoprotein-L3 alpha-Fetoproteins - analysis Biomarkers, Tumor - blood Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - diagnostic imaging Community hepatocellular carcinoma screening Diagnostic reagents industry Hepatitis Humans Liver Neoplasms - blood Liver Neoplasms - diagnosis Liver Neoplasms - diagnostic imaging Mass Screening - statistics & numerical data Middle Aged Retrospective Studies Ultrasonography Ultrasonography - statistics & numerical data Ultrasound imaging |
| title | Did AFP-L3 save ultrasonography in community screening? |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T09%3A39%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Did%20AFP-L3%20save%20ultrasonography%20in%20community%20screening?&rft.jtitle=The%20Kaohsiung%20journal%20of%20medical%20sciences&rft.au=Yen,%20Chih-Wei&rft.date=2018-10&rft.volume=34&rft.issue=10&rft.spage=583&rft.epage=587&rft.pages=583-587&rft.issn=1607-551X&rft.eissn=2410-8650&rft_id=info:doi/10.1016/j.kjms.2018.05.005&rft_dat=%3Cgale_doaj_%3EA722054345%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5813-4b94ad2837191f3dc59046da81fc07da132192a1dd4a745983e53e956a6d7ca53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2119918741&rft_id=info:pmid/30309487&rft_galeid=A722054345&rfr_iscdi=true |